Speciality: Pulmonary Medicine
Description:
A warm welcome to all the medical professionals in this interesting session on biologics target severe allergic asthma, improving lung function and reducing exacerbations.
Biologics are a breakthrough in treating severe allergic asthma, targeting specific immune pathways to reduce inflammation and improve symptoms. In individuals with severe asthma not well-controlled by standard medications, biologics offer a targeted approach, often by blocking key inflammatory molecules like interleukins or immunoglobulin E (IgE). These medications, typically monoclonal antibodies, help reduce asthma exacerbations, improve lung function, and enhance quality of life.
Biologics are especially effective in eosinophilic asthma subtypes, where elevated eosinophil levels indicate a more robust inflammatory response. Treatment selection is guided by patient-specific factors like biomarker profiles and treatment response. While biologics have revolutionized asthma management, their high cost and route of administration (usually via injection or infusion) are important considerations.
However, for individuals with severe allergic asthma unresponsive to traditional therapies, biologics offer hope for better symptom control and improved quality of life.
Therefore, get an overall knowledge on biologics target severe allergic asthma, improving lung function and reducing exacerbations.
See More Webinars @ Hidoc Webinars
1.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
2.
Research uncovers hidden Australian skin cancer epidemic
3.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
4.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
5.
The American College of Physicians updated its recommendations for colorectal cancer screening.
1.
Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options
2.
The Role of Alanine Aminotransferase in Liver Health and Disease
3.
Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation